Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.
Section on Membrane Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD 20892.
Proc Natl Acad Sci U S A. 2022 Sep 20;119(38):e2202490119. doi: 10.1073/pnas.2202490119. Epub 2022 Sep 12.
Muscle cell fusion is a multistep process where the final step of the reaction drives progression beyond early hemifusion events to complete fusion. This step requires activity of the muscle-specific fusogen Myomerger, a single-pass transmembrane protein containing 84 amino acids with an ectodomain that includes two α-helices. Previous studies have demonstrated that Myomerger acts by destabilizing membranes through generation of elastic stresses in the outer leaflet of the plasma membrane. An obvious question is how such destabilizing activity might be regulated to avoid membrane and cellular damage, and how the two juxtaposed helices cooperate in fusion. Using cellular fusion assays and in vitro liposome assays, we report that the two helices possess unique characteristics, both of which are needed for full activity of the protein. We demonstrate that externalized phosphatidylserine (PS), a lipid previously implicated in myoblast fusion, has a determinant role in the regulation of Myomerger activity. The membrane-proximal, amphipathic Helix-1 is normally disordered and its α-helical structure is induced by PS, making membrane interactions more efficacious. The distal, more hydrophobic Helix-2 is intrinsically ordered, possesses an ability to insert into membranes, and augments the membrane-stressing effects of Helix-1. These data reveal that Myomerger fusogenic activity is an exquisitely orchestrated event involving its two ectodomain helices, which are controlled by membrane lipid composition, providing an explanation as to how its membrane-stressing activity is spatially and temporally regulated during the final step of myoblast fusion.
肌细胞融合是一个多步骤的过程,反应的最后一步推动进展超越早期半融合事件,以完成融合。这一步需要肌特异性融合剂 Myomerger 的活性,Myomerger 是一种单次跨膜蛋白,包含 84 个氨基酸,其胞外域包含两个α-螺旋。先前的研究表明,Myomerger 通过在外质层产生弹性应力来破坏质膜来发挥作用。一个明显的问题是这种破坏活性如何被调节以避免膜和细胞损伤,以及两个并列的螺旋如何在融合中协作。使用细胞融合测定和体外脂质体测定,我们报告说这两个螺旋具有独特的特性,这两个特性都是该蛋白完全活性所必需的。我们证明,先前被认为与成肌细胞融合有关的外显化磷脂酰丝氨酸(PS)在 Myomerger 活性的调节中起着决定作用。膜近端的两亲性 Helix-1 通常是无规则的,其α-螺旋结构由 PS 诱导,使膜相互作用更有效。位于远端的、疏水性更强的 Helix-2 本质上是有序的,具有插入膜的能力,并增强了 Helix-1 的膜应力效应。这些数据表明,Myomerger 的融合活性是一个精巧协调的事件,涉及其两个胞外域螺旋,这些螺旋受膜脂组成的控制,解释了其在成肌细胞融合的最后一步中如何在空间和时间上调节其膜破坏活性。